[
  {
    "info": {
      "NCT": "NCT05103358",
      "Protocol_No": "TSC-007",
      "jit": "Caris",
      "trial_name": "Aadi Bioscience TSC-007"
    },
    "disease": {
      "summary": "Advanced Solid Tumor | Neoplasm Metastasis | Metastatic Solid Tumor | ",
      "details": [
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Metastatic;Advanced Stage"
        }
      ]
    },
    "query": {
      "nct": "NCT05103358",
      "title": "Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1 or TSC2 Genes (PRECISION 1)",
      "current_status": "Recruiting",
      "status_verif_date": "September 2022",
      "last_update_date": "September 9, 2022",
      "trial_hold_status": "open",
      "sponsor": "Aadi Bioscience, Inc.",
      "brief_summary": "A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes",
      "conditions": "Tumor | Tumor, Solid | Metastasis | Metastatic Cancer | Cancer | Cancer Metastatic | Tumors | Neoplasms | Neoplasm Metastasis | Solid Tumor | Advanced Solid Tumor | Advanced Cancer | Malignant Solid Tumor | Malignant Solid Neoplasm | Malignant Neoplasm | Malignant Tumor | TSC | TSC1 | TSC2 | Metastatic Solid Tumor | Metastatic Neoplasm",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Arm A: Pathogenic inactivating TSC1 alterations",
          "drug": "nab-sirolimus",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm A: Pathogenic inactivating TSC1 alterations",
              "Gene": "TSC1",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "inactivating",
              "summary": "TSC1 Pathogenic Alteration inactivating  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Arm B: Pathogenic inactivating TSC2 alterations",
          "drug": "nab-sirolimus",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm B: Pathogenic inactivating TSC2 alterations",
              "Gene": "TSC2",
              "Gene2": "Not available",
              "Type": "Alteration",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "inactivating",
              "summary": "TSC2 Pathogenic Alteration inactivating  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-02-08",
      "min_age": "12 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT05103358\" target=\"_blank\">NCT05103358<\/a>"
    }
  }
]
